Financial Instruments (Tables)

3 Months Ended

Mar. 31, 2016

Financial Instruments Disclosure [Abstract]

Cash, Cash Equivalents and Investments [Table Text Block]

	March 31, 2016						December 31, 2015
	Cash and Cash Equivalents		Marketable Securities		Total Estimated Fair Value		Cash and Cash Equivalents		Marketable Securities		Total Estimated Fair Value
Cash	$	1,630	$	—	$	1,630	$	1,938	$	—	$	1,938
Level 1:
Money market funds	$	412	$	—	$	412	$	550	$	—	$	550
U.S. Treasury securities1	—		529		529		—		788		788
Level 2:
Certificate of deposit / time deposits2	$	2,124	$	94	$	2,218	$	2,812	$	118	$	2,930
Total cash, cash equivalents and marketable securities	$	4,166	$	623			$	5,300	$	906

^1.  Available-for-sale securities are reported at estimated fair value with unrealized gains and losses reported as component of accumulated other comprehensive loss. Proceeds from the sale of available-for-sale securities were $260 in the three months ended March 31, 2016.

^2.  Held-to-maturity investments are reported at amortized cost.

Schedule of Notional Amounts of Outstanding Derivative Positions

	March 31, 2016		December 31, 2015
Derivatives designated as hedging instruments:
Foreign currency contracts	$	1	$	10
Commodity contracts	265		356
Derivatives not designated as hedging instruments:
Foreign currency contracts	9,320		8,065
Commodity contracts	16		70

Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)

	Three Months Ended
	March 31,
	2016			2015
Beginning balance	$	(24	)	$	(6	)
Additions and revaluations of derivatives designated as cash flow hedges	10			(16		)
Clearance of hedge results to earnings	7			4
Ending balance	$	(7	)	$	(18	)

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

		Fair Value Using Level 2 Inputs
	Balance Sheet Location	March 31, 2016		December 31, 2015
Asset derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Accounts and notes receivable, net	$	51	$	74
Total asset derivatives1		$	51	$	74
Cash collateral	Other accrued liabilities	$	—	$	7
Liability derivatives:
Derivatives not designated as hedging instruments:
Foreign currency contracts	Other accrued liabilities	$	138	$	80
Commodity contracts	Other accrued liabilities	1		4
Total liability derivatives1		$	139	$	84

^1.  The company's derivative assets and liabilities subject to enforceable master netting arrangements totaled $44 at March 31, 2016 and $35 at December 31, 2015.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

	Amount of Gain (Loss) Recognized in OCI1 (Effective Portion)					Amount of Gain (Loss) Recognized in Income2
Three Months Ended March 31,	2016		2015			2016			2015			Income Statement Classification
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate swaps	$	—	$	—		$	—		$	(1	)	Interest expense
Cash flow hedges:
Foreign currency contracts	—		(2		)	—			8			Net sales
Commodity contracts	16		(20		)	11			(15		)	Cost of goods sold
	16		(22		)	11			(8		)
Derivatives not designated as hedging instruments:
Foreign currency contracts	—		—			(154		)	279			Other income, net3
Foreign currency contracts	—		—			(4		)	—			Net sales
Foreign currency contracts	—		—			—			(11		)	Income from discontinued operations after income taxes
Commodity contracts	—		—			—			2			Cost of goods sold
	—		—			(158		)	270
Total derivatives	$	16	$	(22	)	$	(147	)	$	262

^1.   OCI is defined as other comprehensive income (loss).

^2.  For cash flow hedges, this represents the effective portion of the gain (loss) reclassified from accumulated OCI into income during the period. For the three months ended March 31, 2016 and 2015, there was no material ineffectiveness with regard to the company's cash flow hedges.

^3.   Gain (loss) recognized in other income, net, was partially offset by the related gain (loss) on the foreign currency-denominated monetary assets and liabilities of the company's operations, which were $33 and $(200) for the three months ended March 31, 2016 and 2015, respectively. See Note 5 for additional information.